Claim Ledger
63% answered
Did management answer the analysts?
12 analyst questions audited, 3 evaded or deflected.
View Claim Ledger →
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Bajaj Finserv reported a mixed Q1 FY25. Consolidated PAT grew 10% YoY to INR 2,138 crore, but excluding one-offs, growth was 8%. Revenue rose 35% to INR 31,480 crore. BAGIC posted strong GWP growth of 24% to INR 4,761 crore, though combined ratio worsened to 103.7% due to large commercial claims. BALIC's individual rated new business grew 26%, but PAT fell 37% due to new business strain. Bajaj Finance resumed eCom and Insta EMI card issuance post-RBI embargo. Emerging businesses' losses widened to INR 119 crore. Management highlighted margin pressure from regulatory changes and elevated loan losses, but expects improvement in H2. Key risk: elevated credit costs and collection efficiency in BFL's rural portfolio.
बजाज फिनसर्व की पहली तिमाही (अप्रैल-जून 2024) के नतीजे मिले-जुले रहे। कंपनी का कुल मुनाफा (PAT) पिछले साल की तुलना में 10% बढ़कर 2,138 करोड़ रुपये हुआ। लेकिन एक बार के खास मुनाफे को हटा दें तो यह बढ़ोतरी सिर्फ 8% रही। कंपनी की कमाई (रेवेन्यू) 35% बढ़कर 31,480 करोड़ रुपये हो गई। बजाज ऑलियंज जनरल इंश्योरेंस (BAGIC) का प्रीमियम कलेक्शन 24% बढ़ा, लेकिन बड़े कॉरपोरेट क्लेम के कारण उसका खर्च-से-प्रीमियम अनुपात (Combined Ratio) बिगड़कर 103.7% हो गया। बजाज ऑलियंज लाइफ इंश्योरेंस (BALIC) का नया बिजनेस 26% बढ़ा, लेकिन नए बिजनेस के शुरुआती खर्च के कारण मुनाफा 37% गिर गया। बजाज फाइनेंस ने RBI की पाबंदी हटने के बाद ई-कॉम और इंस्टा ईएमआई कार्ड जारी करना फिर शुरू कर दिया। नए कारोबारों का घाटा बढ़कर 119 करोड़ रुपये हो गया। प्रबंधन ने कहा कि नियमों में बदलाव और बढ़ते कर्ज नुकसान से मार्जिन पर दबाव है, लेकिन दूसरी छमाही में स
Promises0 met · 3 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Promises
3 promises
Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →
Risks
4 risks
Risk Intelligence
Elevated loan losses and collection efficiency in BFL
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Gross Written Premium (BAGIC)
INR 4,761 crore
+24% YoY
BAGIC grew at double the industry pace, gaining market share to 6.5%.
Individual Rated New Business (BALIC)
INR 1.55 lakh policies
+26% YoY
BALIC's IRNB growth outpaced industry and private sector, with market share rising to 9%.
Combined Ratio (BAGIC)
103.7%
+300bps YoY
Deterioration driven by large commercial claims; underwriting profit still positive on NEP basis.
AUM (Bajaj Housing Finance)
INR 97,000 crore
+31% YoY
BHFL AUM nearing INR 1 lakh crore; DRHP filed for potential IPO.
What Changed vs Last Quarter
NEW
BAGIC expects combined ratio to normalize in subsequent quarters
Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.
NEW
BALIC margins may see a pause in expansion this year due to surrender regulations
New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization.
NEW
BFL expects collection efficiency to improve in H2
Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25.
NEW
Bajaj Finserv Health to provide long-term plan in 6-9 months
Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.
DROPPED
BAGIC to maintain above-market growth with balanced profitability
Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.
DROPPED
BALIC to grow faster than industry with improving margins
Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.
DROPPED
Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
NEW RISK
Elevated loan losses and collection efficiency in BFL
BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.
NEW RISK
Impact of new surrender regulations on BALIC margins
New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.
NEW RISK
Large commercial claims in BAGIC may recur
Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.
NEW RISK
Vidal acquisition may lead to customer attrition
Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms.
RISK GONE
Motor TP pricing uncertainty
No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.
RISK GONE
Regulatory risk on surrender charges for life insurance
Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
RISK GONE
Dependence on tender-driven government health and crop business
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
RISK GONE
Persistency pressure in life insurance from older cohorts
37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving.
🤫 Topics management stopped discussing
Mentioned in Q3 FY24, Q4 FY24
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Mentioned in Q1 FY24, Q2 FY24
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Mentioned in Q2 FY24, Q4 FY24
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
Mentioned in Q3 FY24, Q4 FY24
Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
Fast read
Guidance and risk preview
Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.
BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.
View Risks →